Study of a Kindred with Classic Congenital Adrenal Hyperplasia: Diagnostic Challenge due to Phenotypic Variance1
The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
We sought to determine the concordance of the phenotype and genotype in a kindred with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency. The variation in phenotypic expression within this family underscores the difficulty of establishing the diagnosis in the absence of newborn screening, even with a heightened index of suspicion. Steroidogenic profiles were obtained for the three affected siblings. The available clinical history of the two affected aunts was retrieved. Genotyping was performed on several members of the kindred. Detailed sequencing of the entire CYP21 gene of two clinically dissimilar subjects in this family was undertaken to explore the possibility of other mutations or polymorphisms. PCR with ligase detection reaction analysis of CYP21 revealed that the affected family members III-2, III-3, III-4, II-3, and II-4, all were compound heterozygotes carrying the intron 2 point mutation known to interfere with splicing (nucleotide 656 A to G) and the exon 4 point mutation causing a nonconservative substitution of asparagine for isoleucine at codon 172 (I172N). Detailed sequencing of the gene was performed for the two most phenotypically dissimilar subjects. A single silent polymorphism was found in the third nucleotide for codon 248 in patient II-4, but not in patient III-4, and no additional mutations were found. Classic congenital adrenal hyperplasia remains a difficult diagnosis to make in the absence of newborn screening because of the variability of phenotypic expression. Likewise, the variable degree of genital ambiguity in affected females in this family serves to question universal advocacy of prenatal steroid treatment in pregnancies at risk for congenital adrenal hyperplasia. Extensive molecular exploration did not provide an explanation of the phenotypic heterogeneity and supports the possibility of influences other than the CYP21 gene for the observed divergence.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Speiser, P. W., Dupont, J., Zhu, D., Serrat, J., Buegeleisen, M., Tusie-Luna, M. T., Lesser, M., New, M. I., & White, P. C. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115897 · Cited by 572 · cited 1×
“Moreover, the group of patients with the I172N mutation causing a reduction, but not ablation, of 21-hydroxylase activity has been found to contain the widest variation in phenotypes (24, 25).”
BackgroundSelf-citationPang, S., Wallace, M. A., Hofman, L., Thuline, H. C., Dorche, C., Lyon, I. C. T., Dobbins, R. H., Kling, S., Fujieda, K., & Suwa, S. (1988) · Journal of Urology · doi:10.1016/s0022-5347(17)42164-1 · Cited by 392
Wedell, A. (1994) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.78.5.1145 · Cited by 370
Clinical review 54: genetics, diagnosis, and management of 21-hydroxylase deficiency
Miller, W. L. (1994) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.78.2.241 · Cited by 167
Allen, D. B., Hoffman, G. L., Fitzpatrick, P., Laessig, R., Maby, S., & Slyper, A. (1997) · The Journal of Pediatrics · doi:10.1016/s0022-3476(97)70321-4 · Cited by 153 · cited 1×
“False positive reports are most often associated with prematurity or hyperbilirubinemia ( 33 ).”
BackgroundJääskeläinen, J., Levo, A., Voutilainen, R., & Partanen, J. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.10.4271 · Cited by 149 · cited 1×
“Moreover, the group of patients with the I172N mutation causing a reduction, but not ablation, of 21-hydroxylase activity has been found to contain the widest variation in phenotypes (24, 25).”
BackgroundMutations in steroid 21-hydroxylase (CYP21)
White, P. C., Tusie-Luna, M.-T., New, M. I., & Speiser, P. W. (1994) · Human Mutation · doi:10.1002/humu.1380030408 · Cited by 129 · cited 1×
“Detailed sequencing of the entire CYP21 gene of two clinically dissimilar subjects in this family was undertaken in an attempt to explain phenotypic differences between patients with the same apparent genotype (5).”
BackgroundSelf-citationExtraadrenal steroid 21-hydroxylation is not mediated by P450c21.
Mellon, S. H., & Miller, W. L. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114325 · Cited by 121
Difference in transcriptional activity of two homologous CYP21A genes.
Chang, S. F., & Chung, B. C. (1995) · Molecular Endocrinology · doi:10.1210/mend.9.10.8544841 · Cited by 73
Cited by
Congenital adrenal hyperplasia due to 21-hydroxylase deficiency*
White, P. C., & Speiser, P. W. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.3.0398 · Cited by 1,432
“Very few data are available regarding natural variability in genital virilization among family members with the same CYP21 genotype, although nearly normal genitalia without treatment in relatives of highly virilized patients have been reported anecdotally (315, 316).”
BackgroundSelf-citationCongenital adrenal hyperplasia
Speiser, P. W., & White, P. C. (2003) · New England Journal of Medicine · doi:10.1056/nejmra021561 · Cited by 1,405
Self-citationKrone, N., Braun, A., Roscher, A. A., Knorr, D., & Schwarz, H. P. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.3.6441 · Cited by 397
“Phenotypic variance may even be present in siblings (29), which suggests a role for modifiers of 21-hydroxylase transcription, translation, and action.”
BackgroundHall, C. M., Jones, J. A., Meyer-Bahlburg, H. F. L., Dolezal, C., Coleman, M., Foster, P., Price, D. A., & Clayton, P. E. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030696 · Cited by 101
“However, the same genotype, even within families, may be associated with clinically heterogeneous phenotypes (8, 9).”
BackgroundUse of nonradioactive labeling to detect large gene rearrangements in 21-hydroxylase deficiency
Cukier, P., Bachega, T. A. S. S., Mendonça, B. B., & Billerbeck, A. E. C. (2004) · Revista do Hospital das Clínicas · doi:10.1590/s0041-87812004000600010 · Cited by 1
Metadata
- Authors
- Chin, D., Speiser, P. W., Imperato-McGinley, J., Dixit, N., Uli, N., David, R., & Oberfield, S. E.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 1998-06-01
- Volume
- 83
- Issue
- 6
- Pages
- 1940-1945
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W1969346694
- Cited by
- 27
- References
- 9
- FWCI
- 1.01
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.